Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02068157 · ClinicalTrials.gov registry record · Phase 2
Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase 2 study, sponsored by Roswell Park Cancer Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 3
- Enrollment target
NCT02068157 is a Phase 2 study that was terminated before completion, run by Roswell Park Cancer Institute. The registered enrollment target is 3 participants.
The verdict
NCT02068157, a Phase 2 study, was terminated before completion, sponsored by Roswell Park Cancer Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 3 participants
- Enrollment target
Study Summary
This phase II trial studies the effects of interstitial photodynamic therapy in patients with head and neck cancer that has come back. Interstitial photodynamic therapy uses a combination of laser light and a light-sensitive drug called porfimer sodium to destroy tumors. During treatment a laser light is used to activate the drug. Interstitial photodynamic therapy may be an effective treatment for head and neck cancer.
Interventions
- OTHER Laboratory Biomarker Analysis
- DRUG Porfimer Sodium
- DRUG Photodynamic Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2016-11-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02068157
The ClinicalTrials.gov registry entry for NCT02068157 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02068157 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02068157 about?
NCT02068157 is a clinical study titled "Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer". This phase II trial studies the effects of interstitial photodynamic therapy in patients with head and neck cancer that has come back. Interstitial photodynamic therapy uses a combination of laser light and a light-sensitive drug called porfimer sodium to destroy tumors. During treatment a laser lig...
What is the current status of trial NCT02068157?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 3 participants. The study started on 2014-04-01. Estimated completion is 2016-11-04.
What interventions are being tested in trial NCT02068157?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Porfimer Sodium (DRUG), Photodynamic Therapy (DRUG).
Who is sponsoring clinical trial NCT02068157?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.